Listed

Interface Inc: Form 10-Q for the period ended Oct 1, 2017

Filed with the SEC on Nov 9, 2017 and accepted by EDGAR at Nov 9, 2017, 17:01 ET.

Share

Management's discussion and analysis

As filed, 15,691 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our discussions below in this Item 2 are based upon the more detailed discussions about our business, operations and financial condition included in our Annual Report on Form 10-K for the fiscal year ended January 1, 2017, under Item 7 of that Form 10-K. Our discussions here focus on our results during the quarter and nine months ended, or as of, October 1, 2017, and the comparable periods of 2016 for comparison purposes, and, to the extent applicable, any material changes from the information discussed in that Form 10-K or other important intervening developments or information since that time. These discussions should be read in conjunction with that Form 10-K for more detailed and background information.

Forward-Looking Statements

This report contains statements which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include risks and uncertainties associated with economic conditions in the commercial interiors industry, as well as the risks and uncertainties discussed under the heading “Risk Factors” included in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2017, which discussion is hereby incorporated by reference. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.

General

During the quarter ended October 1, 2017, we had net sales of $257.4 million, compared with net sales of $248.3 million in the third quarter last year. During the first nine months of fiscal year 2017, we had net sales of $730.2 million, compared with net sales of $719.1 million in the first nine months of last year. Fluctuations in currency exchange rates had positive impacts on our sales and operating income in the third quarter 2017 versus the prior year period; for the nine-month period ended October 1, 2017, fluctuations in currency exchange rates had a negative impact on our sales but a positive impact on operating income compared with the prior year period. The following table presents the amounts (in U.S. dollars) by which the exchange rates for converting foreign currencies into U.S. dollars have affected our net sales and operating income for the three months and nine months ended October 1, 2017. The impacts of changes in foreign currency presented in the tables are calculated based on applying the prior year period’s average foreign currency exchange rates to the current year period.

(In millions)

Impact of Changes in Foreign Currency on: Three Months Ended October 1, 2017 Nine Months Ended October 1, 2017
Net sales $4.0 $(1.0)
Operating income 0.6 0.2

During the third quarter of 2017, we had net income of $19.4 million, or $0.32 per diluted share, compared with net income of $15.9 million, or $0.25 per diluted share, in the third quarter of 2016. During the nine months ended October 1, 2017, we had net income of $48.9 million, or $0.78 per share, compared with net income of $49.5 million, or $0.76 per share, in the first nine months of 2016. The first nine months of 2017 include $7.3 million of restructuring and asset impairment charges (all of which were recorded in the first quarter) as a continuation of the plans announced in the fourth quarter of 2016, primarily related to closing our FLOR specialty retail stores.

Results of Operations

The following table presents, as a percentage of net sales, certain items included in our Consolidated Condensed Statements of Operations for the three-month and nine-month periods ended October 1, 2017 and October 2, 2016, respectively:

Three Months Ended Oct. 1, 2017 Oct. 2, 2016 Nine Months Ended Oct. 1, 2017 Oct. 2, 2016
Net sales 100.0% 100.0% 100.0% 100.0%
Cost of sales 61.7 62.6 61.1 61.2
Gross profit on sales 38.3 37.4 38.9 38.8
Selling, general and administrative expenses 26.3 27.0 27.1 27.8
Restructuring and Asset Impairment Charges 0.0 0.0 1.0 0.0
Operating income 12.0 10.4 10.9 10.9
Interest/Other expenses 1.0 1.0 0.9 0.8
Income before tax expense 11.0 9.4 9.9 10.1
Income tax expense 3.5 3.0 3.2 3.2
Net income 7.6 6.4 6.7 6.9

Net Sales

Below we provide information regarding net sales, and analyze those results, for the three-month and nine-month periods ended October 1, 2017, and October 2, 2016, respectively.

(In thousands)

Three Months Ended Oct. 1, 2017 Oct. 2, 2016 Percentage Change
Net Sales $257,431 $248,349 3.7%

(In thousands)

Nine Months Ended Oct. 1, 2017 Oct. 2, 2016 Percentage Change
Net Sales $730,233 $719,110 1.5%

For the quarter ended October 1, 2017, net sales increased $9.1 million (3.7%) versus the comparable period in 2016. Currency fluctuations had an approximately $4.0 million (2.0%) positive impact on the 2017 third quarter sales compared to the third quarter of 2016. This positive impact was the result of a strengthening Euro and Australian dollar as compared to the prior year period. On a geographic basis, sales increased in all regions, with Americas commercial sales (defined as Americas sales less the FLOR residential sales) up 2%, sales in Europe up 6% as translated into U.S. dollars (2% in local currency), and sales in Asia-Pacific up 12%. Third quarter sales were negatively impacted by the exit of the FLOR specialty retail stores at the end of the first quarter of 2017, although this was partially offset by gains in FLOR’s other sales channels. Global sales increased most significantly in the corporate office, education, government and healthcare segments. These increases were partially offset by declines in the retail segment and in the residential segment, which is largely a result of the exit of the FLOR specialty retail stores. In the Americas, the increase in sales was primarily due to sales of luxury vinyl tile (“LVT”), which is a hard surface modular flooring product line launched in the first quarter of 2017. In Europe, sales increased 2% in local currency, with increases in the United Kingdom, Germany and Southern and Central Europe. As noted above, due to the strengthening of the Euro, our sales in Europe improved by 6% as translated into U.S. dollars. Sales in Asia-Pacific saw increases across the region with the exception of China.

For the nine months ended October 1, 2017, net sales increased $11.1 million (1.5%) versus the comparable period in 2016. Currency fluctuations had an approximately $1.0 million (less than 1%) negative impact on sales for the first nine months of 2017 as compared to the same period in 2016. On a geographic basis, sales were up 2% in the Americas commercial business and up 5% in Asia-Pacific. In Europe, sales were down approximately 1% both in local currency and as translated into U.S. dollars. We experienced sales increases in our corporate office, education and government segments. These increases were offset by declines in the healthcare and hospitality segments. Sales were also negatively impacted by the exit of FLOR specialty retail stores at the end of the first quarter of 2017. As noted above, we launched LVT in the first quarter of 2017. Sales of these products are progressing according to plan and have been primarily in the Americas, although they were launched in Europe and Asia-Pacific in the second quarter of this year and sales activity in those regions is progressing in line with expectations as well.

Cost and Expenses

The following tables present, on a consolidated basis for our operations, our overall cost of sales and selling, general and administrative expenses for the three-month and nine-month periods ended October 1, 2017 and October 2, 2016, respectively:

(In thousands)

Cost and Expenses Three Months Ended Oct. 1, 2017 Oct. 2, 2016 Percentage Change
Cost of sales $158,887 $155,431 2.2%
Selling, general and administrative expenses 67,633 67,175 0.7%
Total $226,520 $222,606 1.8%

(In thousands)

Cost and Expenses Nine Months Ended Oct. 1, 2017 Oct. 2, 2016 Percentage Change
Cost of sales $445,990 $440,434 1.3%
Selling, general and administrative expenses 197,660 200,108 (1.2%)
Total $643,650 $640,542 0.5%

For the quarter ended October 1, 2017, costs of sales increased $3.5 million (2.2%) as compared to the third quarter of 2016. Fluctuations in currency exchange rates had a small (1%) impact on the comparison. The increase in costs of sales was a function of higher sales for the 2017 third quarter, as sales increased 3.7% versus the prior year period. The percentage increase in costs of sales was lower than the increase in sales due to improved manufacturing performance during the quarter, a result of our productivity and process improvement gains as well as savings from our restructuring activities undertaken in the fourth quarter of 2016. In addition, in the third quarter of 2016, there were costs related to our move to a centralized warehouse facility in the U.S. that did not repeat in 2017. As a percentage of sales, costs of sales decreased to 61.7% for the third quarter of 2017 as compared to 62.6% for the third quarter of 2016 due to the factors noted above. This improvement came despite slightly lower production volumes in the third quarter of 2017 versus the same period in 2016 as well as higher raw material input prices.

For the nine months ended October 1, 2017, cost of sales increased $5.5 million (1.3%) versus the comparable period in 2016. Fluctuations in currency exchange rates did not have a significant impact on the comparison. This increase in costs of sales was largely because of increased sales for the period, as sales increased 1.5% versus the prior year period. As a percentage of sales, our cost of sales decreased slightly to 61.1% for the nine months ended October 1, 2017, from 61.2% for the comparable period in 2016. This decrease is a result of the Company’s productivity initiatives delivering benefits slightly in advance of higher raw material input prices and despite lesser absorption of fixed costs associated with lower production volumes. We expect continued raw material price inflation, as well as less absorption of fixed costs associated with lower production levels, for the balance of 2017 and, as a result, cost of sales as a percentage of sales is expected to increase for the remainder of 2017.

For the three months ended October 1, 2017, selling, general and administrative (“SG&A”) expenses increased $0.5 million (0.7%) versus the comparable period last year. Fluctuations in current exchange rates did not have a significant impact on the comparison. This increase in SG&A expenses is a result of additional incentive based compensation due to higher projected attainment of performance goals in the third quarter of 2017 as compared to the prior year period. This increase in incentive-based compensation was offset almost entirely by (1) lower selling expenses due to the exit of the FLOR specialty retail stores, (2) lower functional expenses as we continue our transition to more centralized services, and (3) savings as a result of our restructuring plans implemented in the fourth quarter of 2016. These savings were realized despite higher expenses associated with our LVT product launches in 2017. As a result of the savings discussed above, as a percentage of sales, our SG&A expenses declined to 26.3% for the three months ended October 1, 2017 versus 27.0% for the comparable period in 2016.

For the nine-month ended October 1, 2017, SG&A expenses decreased $2.5 million (1.2%) versus the comparable period in 2016. This decline was a function of decreases in the first six months of 2017 offset by a slight increae in the three months ended October 1, 2017. Fluctuations in currency exchanges rates did not have a significant impact on the comparison. The decline for the nine-month period was a result of (1) lower functional expenses, as we move towards more centralized services and realize associated savings, (2) lower selling expenses in the second and third quarters of 2017 associated with exiting the FLOR specialty retail stores, and (3) savings associated with our previously announced restructuring plans. These savings were offset by higher incentive compensation due to higher attainment of performance goals in 2017 versus 2016, as well as costs associated with the rollout of our LVT product offerings. Due to these decreases, as well as higher sales for the first nine months of 2017, our SG&A expenses declined to 27.1% of sales as compared to 27.8% of sales for the first nine months of 2016.

Interest Expense

For the three-month period ended October 1, 2017, our interest expense increased $0.2 million to $1.9 million, from $1.7 million in the third quarter of 2016. For the nine-month period ended October 1, 2017, our interest expense increased $0.4 million to $5.2 million, from $4.8 million in the comparable period last year. The increases were due to higher weighted average borrowing rates for the 2017 periods versus those of the 2016 periods as well as higher average daily outstanding borrowing amounts under our Syndicated Credit Facility during the 2017 periods.

Liquidity and Capital Resources

General

At October 1, 2017, we had $78.1 million in cash and cash equivalents. At that date, we had outstanding $173.8 million of term loan borrowings, $60.8 million of revolving loan borrowings and $6.0 million in letters of credit under our Syndicated Credit Facility.

As of October 1, 2017, we could have incurred $183.2 million of additional borrowings under our Syndicated Credit Facility. In addition, we could have incurred an additional $9.8 million of borrowings under our other lines of credit in place at other non-U.S. subsidiaries.

Analysis of Cash Flows

We exited the quarter ended October 1, 2017 with $78.1 million in cash, a decrease of $87.6 million during the first nine months of the year. The decrease in cash was primarily a result of cash outflows for financing activities, with the most significant factors being (1) $81.1 million of cash used to repurchase and retire 4.2 million shares of our outstanding common stock, (2) $62.1 million of cash used to repay borrowings under the Syndicated Credit Facility (including required amortization payments of $11.3 million), and (3) $11.6 million for the payments of dividends. These financing cash outflows were partially offset by $20.0 million of borrowings under our Syndicated Credit Facility. We also used cash of $22.8 million for capital expenditures in the first nine months of 2017. These uses were partially offset by $67.9 million of cash generated from operating activities during the nine-month period. The factors driving the cash from operations were (1) $48.9 million of net income for the period, and (2) $10.8 million of cash generated due to an increase in accounts payable and accruals. These inflows were partially offset by operating cash outflows of $22.4 million due to an increase in inventory.

Market risk

As filed, 2,390 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our discussion below in this Item 3 is based upon the more detailed discussions of our market risk and related matters included in our Annual Report on Form 10-K for the fiscal year ended January 1, 2017 under Item 7A of that Form 10-K. Our discussion here focuses on the period ended October 1, 2017, and any material changes from (or other important intervening developments since the time of) the information discussed in that Form 10-K. This discussion should be read in conjunction with that Form 10-K for more detailed and background information.

At October 1, 2017, we recognized a $30.7 million increase in our foreign currency translation adjustment account compared to January 1, 2017, primarily because of the weakening of the U.S. dollar against certain foreign currencies, particularly the Euro and the Australian dollar.

Sensitivity Analysis. For purposes of specific risk analysis, we use sensitivity analysis to measure the impact that market risk may have on the fair values of our market sensitive instruments.

To perform sensitivity analysis, we assess the risk of loss in fair values associated with the impact of hypothetical changes in interest rates and foreign currency exchange rates on market sensitive instruments.

Because the debt outstanding under our Syndicated Credit Facility has variable interest rates based on an underlying prime lending rate or LIBOR rate, we do not believe changes in interest rates would have any significant impact on the fair value of that debt instrument. Changes in the underlying prime lending rate or LIBOR rate would, however, impact the amount of our interest expense. For a discussion of these hypothetical impacts on our interest expense, please see the discussion in Item 7A of our Annual Report on Form 10-K for the year ended January 1, 2017.

As of October 1, 2017, a 10% decrease or increase in the levels of foreign currency exchange rates against the U.S. dollar, with all other variables held constant, would result in a decrease in the fair value of our financial instruments of $9.6 million or an increase in the fair value of our financial instruments of $11.7 million, respectively. As the impact of offsetting changes in the fair market value of our net foreign investments is not included in the sensitivity model, these results are not indicative of our actual exposure to foreign currency exchange risk.

Controls and procedures

As filed, 984 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was performed under the supervision and with the participation of our management, including our President and Chief Executive Officer and our Vice President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Act”), pursuant to Rule 13a-14(c) under the Act. Based on that evaluation, our President and Chief Executive Officer and our Vice President and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report.

There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 223 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There are no material changes in risk factors in the third quarter of 2017. For a discussion of risk factors, see Part I, Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the fiscal year ended January 1, 2017.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-10-01. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2017-07-03 to 2017-10-01$158.9mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2017-01-02 to 2017-10-01$446.0mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2017-07-03 to 2017-10-01$98.5mus-gaap:GrossProfit
Gross profit9 months2017-01-02 to 2017-10-01$284.2mus-gaap:GrossProfit
Selling, general and administrative3 months2017-07-03 to 2017-10-01$67.6mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2017-01-02 to 2017-10-01$197.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-07-03 to 2017-10-01$30.9mus-gaap:OperatingIncomeLoss
Operating income9 months2017-01-02 to 2017-10-01$79.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-07-03 to 2017-10-01$1.9mus-gaap:InterestExpense
Interest expense9 months2017-01-02 to 2017-10-01$5.2mus-gaap:InterestExpense
Income tax3 months2017-07-03 to 2017-10-01$9.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2017-01-02 to 2017-10-01$23.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-07-03 to 2017-10-01$19.4mus-gaap:NetIncomeLoss
Net income9 months2017-01-02 to 2017-10-01$48.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-07-03 to 2017-10-01$0.32us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2017-01-02 to 2017-10-01$0.78us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-07-03 to 2017-10-01$0.32us-gaap:EarningsPerShareBasic
Basic EPS9 months2017-01-02 to 2017-10-01$0.78us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2017-07-03 to 2017-10-0161,060,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2017-01-02 to 2017-10-0162,672,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2017-01-02 to 2017-10-01$67.9mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure9 months2017-01-02 to 2017-10-01$22.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2017-01-02 to 2017-10-01$11.6mus-gaap:PaymentsOfDividends
Share repurchases9 months2017-01-02 to 2017-10-01$81.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-10-01$78.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-10-01$422.5mus-gaap:AssetsCurrent
Total assetsAt period end2017-10-01$802.4mus-gaap:Assets
Current liabilitiesAt period end2017-10-01$168.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-10-01$470.2mus-gaap:Liabilities
Long-term debtAt period end2017-10-01$219.5mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2017-10-01$15.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2017-10-01$332.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-17-018919. Last ingested by Listed: Nov 12, 2026, 19:48 ET. Listed shows no prices and gives no investment advice.